BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9624741)

  • 21. Human papillomaviruses: pediatric perspectives on a family of multifaceted tumorigenic pathogens.
    Cripe TP
    Pediatr Infect Dis J; 1990 Nov; 9(11):836-44. PubMed ID: 2175876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV detection in cervical cancer patients in northern Poland.
    Dybikowska A; Licznerski P; Podhajska A
    Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus infection. Recent findings on progression to cervical cancer.
    Adimora AA; Quinlivan EB
    Postgrad Med; 1995 Sep; 98(3):109-12, 115-6, 120. PubMed ID: 7675735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts.
    Chan SY; Chew SH; Egawa K; Grussendorf-Conen EI; Honda Y; Rübben A; Tan KC; Bernard HU
    Virology; 1997 Dec; 239(2):296-302. PubMed ID: 9434721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genotype distribution of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan.
    Hagiwara K; Uezato H; Arakaki H; Nonaka S; Nonaka K; Nonaka H; Asato T; Oshiro M; Kariya K; Hattori A
    J Med Virol; 2005 Sep; 77(1):107-12. PubMed ID: 16032719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
    Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
    Harnish DG; Belland LM; Scheid EE; Rohan TE
    Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of human papillomavirus DNA in skin warts from immunocompromised patients but not in semen from men whose wives have abnormal cervical cytology.
    Bakir TM; Shuttleworth D; McKenna D; Munro J
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(3):279-91. PubMed ID: 1338072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
    Carlson JA; Cribier B; Nuovo G; Rohwedder A
    J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomaviruses and the diagnosis of genital microorganisms.
    Mitrani-Rosenbaum S
    Isr J Med Sci; 1994; 30(5-6):443-7. PubMed ID: 8034500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus infections of the genital and respiratory tracts in young children.
    Sinal SH; Woods CR
    Semin Pediatr Infect Dis; 2005 Oct; 16(4):306-16. PubMed ID: 16210110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human papillomavirus and cervical cancer].
    Matsumoto K
    Nihon Rinsho; 2007 Nov; 65(11):2113-24. PubMed ID: 18018579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the humoral immune response to genital papillomaviruses.
    Galloway DA; Jenison SA
    Mol Biol Med; 1990 Feb; 7(1):59-72. PubMed ID: 2157937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies against human papillomavirus infection and cervical cancer.
    Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
    J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of human papillomavirus types in the anogenital tract of females and males.
    Barzon L; Militello V; Pagni S; Franchin E; Dal Bello F; Mengoli C; Palù G
    J Med Virol; 2010 Aug; 82(8):1424-30. PubMed ID: 20572068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malpighian epithelia and papillomavirus infections].
    Chardonnet Y; Béjui-Thivolet F; Viac J
    Arch Anat Cytol Pathol; 1992; 40(4):202-11. PubMed ID: 1338181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue effects of and host response to human papillomavirus infection.
    Jenson AB; Kurman RJ; Lancaster WD
    Dermatol Clin; 1991 Apr; 9(2):203-9. PubMed ID: 1647900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.